================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 16, 2005
___________________________
MediCor Ltd.
(Exact name of Registrant as Specified in its Charter)
Delaware 0-50442 14-1871462
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
4560 South Decatur Boulevard, Suite 300, Las Vegas, NV 89103
(Address of Principal Executive Offices)
(702) 932-4560
(Registrant's Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
================================================================================
- --------------------------------------------------------------------------------
Item 2.02 Results of Operations and Financial Condition
MediCor, Ltd. (the "Company") issued a press release on May 16, 2005. The
press release announced the Company's earnings for the quarter ending March 31,
2005 and the Company's wholly owned subsidiary, MediCor Aesthetics will be the
exclusive distributor in the United States for Biosil inflatable saline breast
implants. A copy of the press release is attached hereto as Exhibit 99.1 and
incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
Exhibit No. Description
99.1 Copy of press release issued by the Company on May 16, 2005.
- --------------------------------------------------------------------------------
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
MEDICOR, LTD.
By: /s/ Theodore R Maloney
----------------------
Name: Theodore R. Maloney
Title: Chief Executive Officer
Dated: May 16, 2005